Separate FDA Guidance On HIPAA Privacy Requested By Device Reps
This article was originally published in The Gray Sheet
Executive Summary
FDA guidance on the HIPAA privacy rule should clarify when protected health information (PHI) used in clinical research can be disclosed, according to device manufacturers
You may also be interested in...
HIPAA Could Prevent Future Genzyme Marker Study For Knee Defects
The Health Insurance Portability & Accountability Act of 1996 may represent an obstacle to effectiveness testing of tissue products for the repair or replacement of articular cartilage defects in the knee
HIPAA Could Prevent Future Genzyme Marker Study For Knee Defects
The Health Insurance Portability & Accountability Act of 1996 may represent an obstacle to effectiveness testing of tissue products for the repair or replacement of articular cartilage defects in the knee
AHA Advice On HIPAA: Take A Cautious Approach To “Associate” Contracts
Hospitals should be careful when designating vendors and other contractors as "business associates" to avoid excessive requirements under the HIPAA privacy rule, according to the American Hospital Association